Gabelli Funds LLC Invitae Corp Transaction History

Gabelli Funds LLC

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 10, 2022	SELL	$1.9 - $8.63 $1,900 - $8,630	-1,000 Reduced 2.63%	37,000 $91,000
Q2 2022 Aug 12, 2022	BUY	$2.13 - $9.01 $19,170 - $81,090	9,000 Added 31.03%	38,000 $93,000
Q1 2022 May 13, 2022	BUY	$6.28 - $15.59 $182,120 - $452,110	29,000 New	29,000 $231,000
Q4 2021 Feb 11, 2022	SELL	$14.7 - $28.67 $117,600 - $229,360	-8,000 Closed	0 $0
Q3 2021 Nov 12, 2021	BUY	$24.31 - $33.6 $12,155 - $16,800	500 Added 6.67%	8,000 $227,000

Q4 2020 Feb 05, 2021	SELL	$39.09 - $57.4 $46,908 - $68,880	-1,200 Reduced 13.79%	7,500 $314,000
Q3 2020 Nov 06, 2020	SELL	$28.43 - $44.67 $8,529 - $13,401	-300 Reduced 3.33%	8,700 $377,000
Q2 2020 Aug 13, 2020	BUY	$11.71 - $30.29 $105,390 - $272,610	9,000 New	9,000 $273,000
Q1 2019 May 02, 2019	SELL	$10.65 - $25.75 $191,700 - $463,500	-18,000 Closed	0 $0
Q4 2018 Jan 30, 2019	SELL	$9.26 - $16.38 $18,520 - $32,759	-2,000 Reduced 10.0%	18,000 $199,000
Q2 2018 Aug 10, 2018	SELL	$4.87 - $8.42 $9,740 - $16,840	-2,000 Reduced 9.09%	20,000 $147,000
Q1 2018 May 09, 2018	BUY	$4.69 - $10.05 $8,911 - $19,095	1,900 Added 9.45%	22,000 $103,000
Q4 2017 Feb 02, 2018	BUY	$7.86 - $9.99 $47,946 - $60,939	6,100 Added 43.57%	20,100 $183,000
Q3 2017 Nov 01, 2017	BUY	$8.89 - $10.4 $124,460 - $145,600	14,000	14,000 $131,000

7.66M

Ticker NVTA
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 235,266,000
Description
Invitae Corporation, a medical genetics company, integrates genetic information into mainstream medicine to improve healthcare of people in the United States, Canada, and internationally. The company offers genetic tests in various clinical areas, including hereditary cancer, cardiology, neurology, pediatrics, oncology, metabolic conditions, and...

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

Stay updated on Gabelli Funds LLC with notifications on news.